Staurosporine induces apoptosis in human papillomavirus positive oral cancer cells at G2/M phase by disrupting mitochondrial membrane potential and modulation of cell cytoskeleton

Oral Oncology

Volumn 45, Issue 11, 2009, Pages 974-979

  Sarkar, Jayanta ^a   Singh, Neetu ^a   Meena, Sanjeev ^a   Sinha, Sudhir ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Apoptosis; Cell cycle; Cell cytoskeleton; Mitochondrial membrane potential; Oral cancer; Staurosporine

Indexed keywords

CASPASE 3; F ACTIN; STAUROSPORINE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL DIVISION; CELL STRAIN KB; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DRUG EXPOSURE; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MICROTUBULE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUTH CARCINOMA; NUCLEOSOME; PRIORITY JOURNAL; WART VIRUS;

ACTINS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; ENZYME INHIBITORS; G2 PHASE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, FLUORESCENCE; MICROTUBULES; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; STAUROSPORINE;

EID: 70349938073     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.04.009     Document Type: Article

References (36)

1. Omura S., Iwai Y., Hirano A., Nakagawa A., Awaya J., Tsuchya H., et al. A new alkaloid AM-2282 OF streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J Antibiot 30 4 (1977) 275-282
2. Zhang H., Vollmer M., De Geyter M., Durrenberger M., and De Geyter C. Apoptosis and differentiation induced by staurosporine in granulosa tumor cells is coupled with activation of JNK and suppression of p38 MAPK. Int J Oncol 26 6 (2005) 1575-1580
3. Takehara T., Liu X., Fujimoto J., Friedman S.L., and Takahashi H. Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 34 1 (2001) 55-61
4. Giuliano M., Bellavia G., Lauricella M., D'Anneo A., Vassallo B., Vento R., et al. Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL. Int J Mol Med 13 4 (2004) 565-571
5. Knox K.A., Finney M., Milner A.E., Gregory C.D., Wakelam M.J., Michell R.H., et al. Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines. Int J Cancer 52 6 (1992) 959-966
6. Suzuki K., Azuma Y., Onishi Y., Kizaki H., and Ishimura Y. Biphasic effect of staurosporine on thymocyte apoptosis. Biochem Mol Biol Int 35 5 (1995) 1085-1092
7. McCarthy M.J., Rubin L.L., and Philpott K.L. Involvement of caspases in sympathetic neuron apoptosis. J Cell Sci 110 Pt 18 (1997) 2165-2173
8. MacManus J.P., Rasquinha I., Black M.A., Laferriere N.B., Monette R., Walker T., et al. Glutamate-treated rat cortical neuronal cultures die in a way different from the classical apoptosis induced by staurosporine. Exp Cell Res 233 2 (1997) 310-320
9. Feng G., and Kaplowitz N. Mechanism of staurosporine-induced apoptosis in murine hepatocytes. Am J Physiol Gastrointest Liver Physiol 282 5 (2002) G825-G834
10. Weil M., Jacobson M.D., Coles H.S., Davies T.J., Gardner R.L., Raff K.D., et al. Constitutive expression of the machinery for programmed cell death. J Cell Biol 133 5 (1996) 1053-1059
11. Gescher A. Staurosporine analogues - pharmacological toys or useful antitumour agents?. Crit Rev Oncol Hematol 34 2 (2000) 127-135
12. Gil J., Almeida S., Oliveira C.R., and Rego A.C. Cytosolic and mitochondrial ROS in staurosporine-induced retinal cell apoptosis. Free Radic Biol Med 35 11 (2003) 1500-1514
13. Heerdt B.G., Houston M.A., Mariadason J.M., and Augenlicht L.H. Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (deltapsim). Cancer Res 60 23 (2000) 6704-6713
14. Chandele A., Prasad V., Jagtap J.C., Shukla R., and Shastry P.R. Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. Neoplasia 6 1 (2004) 29-40
15. Wang Y., Zhang B., Peng X., Perpetua M., and Harbrecht B.G. Bcl-xL prevents staurosporine-induced hepatocyte apoptosis by restoring protein kinase B/mitogen-activated protein kinase activity and mitochondria integrity. J Cell Physiol 215 3 (2008) 676-683
16. Wang S., Wang J.A., Li J., Zhou J., and Wang H. Voltage-dependent potassium channels are involved in staurosporine-induced apoptosis of rat mesenchymal stem cells. Cell Biol Int 32 2 (2008) 312-319
17. Reddout N., Christensen T., Bunnel A., Jensen D., Johnson D., O'Malley S., et al. High risk HPV types 18, 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect Agent Cancer 2 (2007) 21
18. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288 2 (1996) F55-F78
19. Yang X., Hao Y., Pater M.M., Tang S.C., and Pater A. Enhanced expression of anti-apoptotic proteins in human papillomavirus immortalized and cigarette smoke condensate transformed human endocervical cells: correlation with resistance to apoptosis induced by DNA damage. Mol Carcinog 22 2 (1998) 95-101
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 1-2 (1983) 55-63
21. Stepczynska A., Lauber K., Engels I.H., Janssen O., Kabelitz D., Wesselborg S., et al. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 20 10 (2001) 1193-1202
22. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35 4 (2007) 495-516
23. Swe M., Bay B.H., and Sit K.H. Interphase and M-phase oral KB carcinoma cells are targetted in staurosporine-induced apoptosis. Cancer Lett 104 2 (1996) 145-152
24. Zhang Y.X., Yu S.B., Ou-Yang J.P., Xia D., Wang M., and Li J.R. Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine. Acta Pharmacol Sin 26 11 (2005) 1365-1372
25. Otsubo A., Bhawal U.K., Nomura Y., Mitani Y., Ozawa K., Kuniyasu H., et al. UCN-01 (7-hydroxystaurosporine) induces apoptosis and G1 arrest of both primary and metastatic oral cancer cell lines in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 3 (2007) 391-397
26. Thompson D.A., Belinsky G., Chang T.H., Jones D.L., Schlegel R., and Munger K. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene 15 25 (1997) 3025-3035
27. Bernard B., Pretet J.L., Charlot J.F., and Mougin C. Human papillomaviruses type 16+ and 18+ cervical carcinoma cells are sensitive to staurosporine-mediated apoptosis. Biol Cell 95 1 (2003) 17-26
28. Arnoult D., Gaume B., Karbowski M., Sharpe J.C., Cecconi F., and Youle R.J. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. Embo J 22 17 (2003) 4385-4399
29. Sakahira H., Enari M., and Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391 6662 (1998) 96-99
30. Margolis R.L., and Wilson L. Microtubule treadmilling: what goes around comes around. Bioessays 20 10 (1998) 830-836
31. Heggeness M.H., Simon M., and Singer S.J. Association of mitochondria with microtubules in cultured cells. Proc Natl Acad Sci USA 75 8 (1978) 3863-3866
32. Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Rubini C., Mariggio M.A., et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 89 12 (2003) 2244-2248
33. Tanaka C., Uzawa K., Shibahara T., Yokoe H., Noma H., and Tanzawa H. Expression of an inhibitor of apoptosis, surviving, in oral carcinogenesis. J Dent Res 82 8 (2003) 607-611
34. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 6711 (1998) 580-584
35. Cotter T.G., Lennon S.V., Glynn J.M., and Green D.R. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 52 4 (1992) 997-1005
36. Cervinka M., Cerman J., and Rudolf E. Apoptosis in Hep2 cells treated with etoposide and colchicine. Cancer Detect Prev 28 3 (2004) 214-226